chr12-51705532-A-C

Variant summary

Our verdict is Uncertain significance.
+5 Uncertain · Hot
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 5 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_ModerateO6_SupportingO7_SupportingO8_Supporting

The NM_001330260.2(SCN8A):c.1250A>C (p.Gln417Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The gene SCN8A is a cancer driver gene (CancerMine: 1 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 9.32). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (no review stars).

Frequency

Genomes: not found (cov: 32)

Consequence

SCN8A
NM_001330260.2 missense

Scores

15
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1

Conservation

PhyloP100: 9.32

Publications

3 publications found
Variant links:
Genes affected
SCN8A (HGNC:10596): (sodium voltage-gated channel alpha subunit 8) This gene encodes a member of the sodium channel alpha subunit gene family. The encoded protein forms the ion pore region of the voltage-gated sodium channel. This protein is essential for the rapid membrane depolarization that occurs during the formation of the action potential in excitable neurons. Mutations in this gene are associated with cognitive disability, pancerebellar atrophy and ataxia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
SCN8A Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen
  • developmental and epileptic encephalopathy, 13
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • cognitive impairment with or without cerebellar ataxia
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • seizures, benign familial infantile, 5
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • benign familial infantile epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myoclonus, familial, 2
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001330260.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 5 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])
O6Computational evidence supports deleterious effect
Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect
O7Mutational hotspot or critical domain
Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 8 pathogenic, 0 benign (OR vs. background: 85.0); Variant does not impact splicing — splice-hotspot path not applicable
O8Missense constraint in gene or region
Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 10.45 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001330260.2. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

SCN8A NM_001330260.2
MANE Select
HGVSc / HGVSpc.1250A>Cp.Gln417Pro
Exon rankExon 10 of 27
missense
Prot: NP_001317189.1UniProt: Q9UQD0-2
SCN8A NM_014191.4
MANE Plus Clinical
HGVSc / HGVSpc.1250A>Cp.Gln417Pro
Exon rankExon 10 of 27
missense
Prot: NP_055006.1UniProt: Q9UQD0-1
SCN8A NM_001177984.3
HGVSc / HGVSpc.1250A>Cp.Gln417Pro
Exon rankExon 10 of 26
missense
Prot: NP_001171455.1UniProt: Q9UQD0-5

Ensembl Transcripts

SCN8A ENST00000354534.11
TSL:1MANE Plus Clinical
HGVSc / HGVSpc.1250A>Cp.Gln417Pro
Exon rankExon 10 of 27
missense
Prot: ENSP00000346534.4UniProt: Q9UQD0-1
SCN8A ENST00000627620.5
TSL:5MANE Select
HGVSc / HGVSpc.1250A>Cp.Gln417Pro
Exon rankExon 10 of 27
missense
Prot: ENSP00000487583.2UniProt: Q9UQD0-2
SCN8A ENST00000599343.5
TSL:5
HGVSc / HGVSpc.1250A>Cp.Gln417Pro
Exon rankExon 9 of 26
missense
Prot: ENSP00000476447.3UniProt: Q9UQD0-3

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:31
GnomAD4 genome
Cov:32
Showing 3 sources

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Early-infantile DEE (1)
-
1
-
Inborn genetic diseases (1)

Computational Scores

AlphaGenome AVI
Pathogenic28
AlphaMissense
Pathogenic1.0
BayesDel_addAF
Pathogenic0.52D
BayesDel_noAF
Pathogenic0.52
CADD
Pathogenic27
DANN
Uncertain1.0
DEOGEN2
Pathogenic0.98D
Eigen
Pathogenic0.84
Eigen_PC
Pathogenic0.80
FATHMM_MKL
Uncertain0.96D
FuncVEP CTI
Pathogenic1.0
GPN-Star LLR
N/A-11
GPN-Star score
N/A11
LIST_S2
Uncertain0.97D
M_CAP
Pathogenic0.81D
MetaRNN
Pathogenic0.88D
MetaSVM
Pathogenic1.1D
Mutation Taster
N/A3/97disease causing (ClinVar)
MutationAssessor
Pathogenic3.1M
PhyloP100
Pathogenic9.3
popEVE
Pathogenic-6.0
PrimateAI
Pathogenic0.85D
PROVEAN
Pathogenic-5.9D
REVEL
Pathogenic0.90
Sift
Pathogenic0.0D
Sift4G
Uncertain0.0030D
Varity_R
N/A0.98
VESM-3B
Benign-17
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.